Skip to main content

Visit our other sites

jnj.com
jnjinnovation network
Quickfire Challenges

Main navigation

Home
About us
Partner with us
Blog
News
Challenges
Video hub
Connect with Us

News

Maintabs

All news
Press releases
In the media
Partner news
Social
Other News

Article view
List view

Refine by

Refine by

Type

In the media
JNJ Press releases
(-) Partner news

Period

2020
2019
2018
(-) 2017
2016
2015
2014
2013
2012
2011
2010
2009
2008

Jan
Mar
Apr
Jun
Jul
Sep
Nov

Locations & regions

Focus area

Clear filters

News

1 November 2017

On Target Laboratories secures $40 million financing led by Johnson & Johnson Innovation – JJDC, Inc. (JJDC)

Read full story

25 September 2017

Fusion Pharmaceuticals Completes Oversubscribed Series A Financing Totaling $46 Million USD to Develop Targeted Alpha Therapeutics

Read full story

21 September 2017

Provention Bio Announces Licensing Agreements with Janssen for Two Clinical-Stage Immunology Assets

Read full story

Accelerator Corporation Announces Series A Financing in Rodeo Therapeutics to Focus on Small-Molecule Regenerative Therapies

Read full story

BlackThorn Therapeutics Enrolls First Patient in Phase 2a Study of Lead Compound, BTRX-246040, in Major Depressive Disorder

Read full story

E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline

Read full story

Provention Bio, Inc. Appoints Eleanor L. Ramos, MD, as Chief Medical Officer and Chief Operating Officer

Read full story

Provention Bio, Inc. Secures $28.4 Million Founding Financing to Fund Development Targeting the Interception and Prevention of Immune-Mediated Disease

Read full story

Aelix Therapeutics appoints HIV expert as CMO

Read full story

23 February 2017

FACIT-Seeded Fusion Pharmaceuticals Closes US$25M Series A Led by Johnson & Johnson Innovation

Read full story

17 February 2017

Ethicon Announces Agreement to Acquire Torax Medical, Inc.

Read full story

26 January 2017

Verb Surgical Delivers Digital Surgery Prototype Demonstration to Collaboration Partners

Read full story

BlackThorn Therapeutics Secures $14 Million in Series A Extension Financing

Read full story

Sidebar

Currently trending

Currently trending

Cue Receives $481 Million Award by DOD and HHS to Expand Domestic Production Capacity and Provide 6 Million Molecular, Point-of-Care COVID-19 Tests
BaseLaunch announces that Johnson & Johnson Innovation has renewed its commitment becoming latest strategic partner in the second phase
Dr. Sadasivan Vidyasagar, Associate Professor at University of Florida, and entrinsic bioscience CEO Stephen Gatto, Receive University of Florida's 'Invention of the Year 2020' Award
XWPharma Announces $40 Million Financing and Appoints Leonard Blum as Chief Executive Officer
ESCAPE Bio Closes $73 Million in Crossover Financing to Advance Clinical Development of Precision Neurology Medicines for Genetic Neurodegeneration
Rodeo Therapeutics Nominates First-in-Class Oral Development Candidate for Inflammatory Bowel Disease
Johnson & Johnson Innovation and BARDA Select a Surge Force of Companies with the Aim to Combat the COVID-19 Pandemic as Part of Its BLUE KNIGHT™ Collaboration
Johnson & Johnson Innovation and Janssen Announce the Awardees of the World Without Disease Call-for-Proposal
GI Windows Raises $16.4M in Series A-1 Financing
Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen’s Leadership in Novel Treatments for Autoimmune Diseases

Trending

Trending

Paul Stoffels, M.D., Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, discusses the value of collaboration

Johnson & Johnson Innovation, Change One Thing, Change Everything: Medopad

Johnson & Johnson Innovation, Change One Thing, Change Everything: Exonate